Author:
Montalescot Gilles,Gallo Richard,White Harvey D.,Cohen Marc,Steg Ph. Gabriel,Aylward Philip E.G.,Bode Christoph,Chiariello Massimo,King Spencer B.,Harrington Robert A.,Desmet Walter J.,Macaya Carlos,Steinhubl Steven R.
Subject
Cardiology and Cardiovascular Medicine
Reference30 articles.
1. Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty;Karsch;J Am Coll Cardiol,1996
2. Multicenter, prospective, double-blind randomized comparison of enoxaparin versus unfractionated heparin for percutaneous coronary interventions (abstr);Dudek;Am J Cardiol,2000
3. The Zuerich Enoxaparin versus Unfractionated heparin Study (ZEUS) in PCI: a prospective randomized non inferiority study (abstr);Bertel;Eur Heart J,2006
4. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial;Gibson;J Am Coll Cardiol,2006
5. A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions;Natarajan;Am Heart J,2006
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献